These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37364726)
1. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors. Godinez J; Lee CY; Schwans JP Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726 [TBL] [Abstract][Full Text] [Related]
3. Identification of Compounds for Butyrylcholinesterase Inhibition. Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114 [TBL] [Abstract][Full Text] [Related]
4. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment. Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169 [TBL] [Abstract][Full Text] [Related]
5. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies. Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519 [TBL] [Abstract][Full Text] [Related]
8. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease. Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612 [TBL] [Abstract][Full Text] [Related]
9. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase. Atay MS; Sari S; Bodur E Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors. Yu D; Yang C; Liu Y; Lu T; Li L; Chen G; Liu Z; Li Y Sci Rep; 2023 Mar; 13(1):4877. PubMed ID: 36966194 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives. Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279 [TBL] [Abstract][Full Text] [Related]
15. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site. Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400 [TBL] [Abstract][Full Text] [Related]
16. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824 [TBL] [Abstract][Full Text] [Related]
17. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones. Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835 [TBL] [Abstract][Full Text] [Related]
18. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids. Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490 [TBL] [Abstract][Full Text] [Related]
19. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies. Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297 [TBL] [Abstract][Full Text] [Related]
20. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults. Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]